nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2C19—epilepsy syndrome	0.12	0.423	CbGaD
Etoricoxib—CYP2D6—epilepsy syndrome	0.0893	0.314	CbGaD
Etoricoxib—PTGS2—epilepsy syndrome	0.075	0.263	CbGaD
Etoricoxib—CYP2E1—Trimethadione—epilepsy syndrome	0.0221	0.0483	CbGbCtD
Etoricoxib—CYP2E1—Felbamate—epilepsy syndrome	0.0221	0.0483	CbGbCtD
Etoricoxib—CYP2E1—Clonazepam—epilepsy syndrome	0.0188	0.0411	CbGbCtD
Etoricoxib—CYP2E1—Rufinamide—epilepsy syndrome	0.0153	0.0335	CbGbCtD
Etoricoxib—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0149	0.0326	CbGbCtD
Etoricoxib—CYP2C19—Trimethadione—epilepsy syndrome	0.0138	0.0303	CbGbCtD
Etoricoxib—CYP2C19—Felbamate—epilepsy syndrome	0.0138	0.0303	CbGbCtD
Etoricoxib—CYP2C19—Fosphenytoin—epilepsy syndrome	0.013	0.0285	CbGbCtD
Etoricoxib—CYP2E1—Propofol—epilepsy syndrome	0.0125	0.0273	CbGbCtD
Etoricoxib—CYP2E1—Phenobarbital—epilepsy syndrome	0.0119	0.0261	CbGbCtD
Etoricoxib—CYP2E1—Midazolam—epilepsy syndrome	0.0117	0.0257	CbGbCtD
Etoricoxib—CYP2C9—Trimethadione—epilepsy syndrome	0.0115	0.0252	CbGbCtD
Etoricoxib—CYP2E1—Diazepam—epilepsy syndrome	0.0113	0.0247	CbGbCtD
Etoricoxib—CYP2C19—Clobazam—epilepsy syndrome	0.0113	0.0247	CbGbCtD
Etoricoxib—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0108	0.0237	CbGbCtD
Etoricoxib—CYP2C19—Carbamazepine—epilepsy syndrome	0.00934	0.0205	CbGbCtD
Etoricoxib—CYP2C19—Primidone—epilepsy syndrome	0.00872	0.0191	CbGbCtD
Etoricoxib—CYP1A2—Carbamazepine—epilepsy syndrome	0.00862	0.0189	CbGbCtD
Etoricoxib—CYP2C19—Phenytoin—epilepsy syndrome	0.00838	0.0184	CbGbCtD
Etoricoxib—CYP1A2—Primidone—epilepsy syndrome	0.00804	0.0176	CbGbCtD
Etoricoxib—CYP2C19—Propofol—epilepsy syndrome	0.00781	0.0171	CbGbCtD
Etoricoxib—CYP2C9—Carbamazepine—epilepsy syndrome	0.00776	0.017	CbGbCtD
Etoricoxib—CYP2C19—Phenobarbital—epilepsy syndrome	0.00747	0.0164	CbGbCtD
Etoricoxib—CYP2C9—Primidone—epilepsy syndrome	0.00725	0.0159	CbGbCtD
Etoricoxib—CYP1A2—Propofol—epilepsy syndrome	0.00721	0.0158	CbGbCtD
Etoricoxib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00719	0.0158	CbGbCtD
Etoricoxib—CYP2C19—Diazepam—epilepsy syndrome	0.00708	0.0155	CbGbCtD
Etoricoxib—CYP2C9—Phenytoin—epilepsy syndrome	0.00696	0.0153	CbGbCtD
Etoricoxib—CYP2C19—Zonisamide—epilepsy syndrome	0.00691	0.0151	CbGbCtD
Etoricoxib—CYP1A2—Phenobarbital—epilepsy syndrome	0.00689	0.0151	CbGbCtD
Etoricoxib—CYP3A4—Felbamate—epilepsy syndrome	0.00668	0.0146	CbGbCtD
Etoricoxib—CYP3A4—Trimethadione—epilepsy syndrome	0.00668	0.0146	CbGbCtD
Etoricoxib—CYP1A2—Diazepam—epilepsy syndrome	0.00653	0.0143	CbGbCtD
Etoricoxib—CYP2C9—Propofol—epilepsy syndrome	0.00649	0.0142	CbGbCtD
Etoricoxib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00628	0.0138	CbGbCtD
Etoricoxib—CYP2C9—Phenobarbital—epilepsy syndrome	0.00621	0.0136	CbGbCtD
Etoricoxib—CYP2D6—Propofol—epilepsy syndrome	0.00594	0.013	CbGbCtD
Etoricoxib—CYP2C9—Diazepam—epilepsy syndrome	0.00588	0.0129	CbGbCtD
Etoricoxib—CYP3A4—Clonazepam—epilepsy syndrome	0.00568	0.0125	CbGbCtD
Etoricoxib—CYP2C19—Valproic Acid—epilepsy syndrome	0.00558	0.0122	CbGbCtD
Etoricoxib—CYP3A4—Clobazam—epilepsy syndrome	0.00545	0.0119	CbGbCtD
Etoricoxib—CYP1A2—Valproic Acid—epilepsy syndrome	0.00515	0.0113	CbGbCtD
Etoricoxib—CYP2C19—Topiramate—epilepsy syndrome	0.00503	0.011	CbGbCtD
Etoricoxib—CYP2C9—Valproic Acid—epilepsy syndrome	0.00464	0.0102	CbGbCtD
Etoricoxib—CYP3A4—Rufinamide—epilepsy syndrome	0.00463	0.0102	CbGbCtD
Etoricoxib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00451	0.00989	CbGbCtD
Etoricoxib—CYP3A4—Primidone—epilepsy syndrome	0.00421	0.00924	CbGbCtD
Etoricoxib—CYP3A4—Phenytoin—epilepsy syndrome	0.00405	0.00887	CbGbCtD
Etoricoxib—CYP3A4—Propofol—epilepsy syndrome	0.00378	0.00828	CbGbCtD
Etoricoxib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00361	0.00791	CbGbCtD
Etoricoxib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00361	0.00791	CbGbCtD
Etoricoxib—CYP3A4—Midazolam—epilepsy syndrome	0.00356	0.0078	CbGbCtD
Etoricoxib—CYP3A4—Diazepam—epilepsy syndrome	0.00342	0.0075	CbGbCtD
Etoricoxib—CYP3A4—Zonisamide—epilepsy syndrome	0.00334	0.00732	CbGbCtD
Etoricoxib—CYP3A4—Valproic Acid—epilepsy syndrome	0.0027	0.00591	CbGbCtD
Etoricoxib—CYP3A4—Topiramate—epilepsy syndrome	0.00243	0.00533	CbGbCtD
Etoricoxib—MAPK14—hindbrain—epilepsy syndrome	0.00117	0.135	CbGeAlD
Etoricoxib—Celecoxib—CA4—epilepsy syndrome	0.000839	0.246	CrCbGaD
Etoricoxib—MAPK14—brainstem—epilepsy syndrome	0.000668	0.0771	CbGeAlD
Etoricoxib—MAPK14—forebrain—epilepsy syndrome	0.000645	0.0744	CbGeAlD
Etoricoxib—Vemurafenib—ABCG2—epilepsy syndrome	0.000608	0.178	CrCbGaD
Etoricoxib—MAPK14—telencephalon—epilepsy syndrome	0.000593	0.0684	CbGeAlD
Etoricoxib—MAPK14—spinal cord—epilepsy syndrome	0.000415	0.0479	CbGeAlD
Etoricoxib—MAPK14—head—epilepsy syndrome	0.000369	0.0426	CbGeAlD
Etoricoxib—Vemurafenib—CYP2D6—epilepsy syndrome	0.000354	0.104	CrCbGaD
Etoricoxib—MAPK14—nervous system—epilepsy syndrome	0.00035	0.0404	CbGeAlD
Etoricoxib—MAPK14—central nervous system—epilepsy syndrome	0.000337	0.0389	CbGeAlD
Etoricoxib—MAPK14—cerebellum—epilepsy syndrome	0.000329	0.038	CbGeAlD
Etoricoxib—Vismodegib—ABCG2—epilepsy syndrome	0.000306	0.0897	CrCbGaD
Etoricoxib—CYP2D6—hindbrain—epilepsy syndrome	0.000288	0.0333	CbGeAlD
Etoricoxib—MAPK14—brain—epilepsy syndrome	0.000267	0.0309	CbGeAlD
Etoricoxib—Vemurafenib—ALB—epilepsy syndrome	0.000265	0.0777	CrCbGaD
Etoricoxib—Vismodegib—CYP2C19—epilepsy syndrome	0.000241	0.0706	CrCbGaD
Etoricoxib—Celecoxib—CYP2D6—epilepsy syndrome	0.000208	0.061	CrCbGaD
Etoricoxib—PTGS2—forebrain—epilepsy syndrome	0.000185	0.0214	CbGeAlD
Etoricoxib—CYP2E1—telencephalon—epilepsy syndrome	0.000185	0.0214	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—epilepsy syndrome	0.000175	0.0513	CrCbGaD
Etoricoxib—PTGS2—telencephalon—epilepsy syndrome	0.00017	0.0197	CbGeAlD
Etoricoxib—CYP2D6—brainstem—epilepsy syndrome	0.000165	0.0191	CbGeAlD
Etoricoxib—CYP2D6—forebrain—epilepsy syndrome	0.000159	0.0184	CbGeAlD
Etoricoxib—Celecoxib—ALB—epilepsy syndrome	0.000156	0.0457	CrCbGaD
Etoricoxib—CYP2D6—telencephalon—epilepsy syndrome	0.000147	0.0169	CbGeAlD
Etoricoxib—CYP2E1—medulla oblongata—epilepsy syndrome	0.000145	0.0168	CbGeAlD
Etoricoxib—PTGS2—medulla oblongata—epilepsy syndrome	0.000134	0.0155	CbGeAlD
Etoricoxib—Vismodegib—ALB—epilepsy syndrome	0.000134	0.0391	CrCbGaD
Etoricoxib—CYP2E1—spinal cord—epilepsy syndrome	0.00013	0.015	CbGeAlD
Etoricoxib—Vismodegib—ABCB1—epilepsy syndrome	0.000127	0.0374	CrCbGaD
Etoricoxib—PTGS2—midbrain—epilepsy syndrome	0.000122	0.0141	CbGeAlD
Etoricoxib—PTGS2—spinal cord—epilepsy syndrome	0.000119	0.0138	CbGeAlD
Etoricoxib—CYP2E1—head—epilepsy syndrome	0.000115	0.0133	CbGeAlD
Etoricoxib—CYP2E1—nervous system—epilepsy syndrome	0.000109	0.0126	CbGeAlD
Etoricoxib—PTGS2—head—epilepsy syndrome	0.000106	0.0123	CbGeAlD
Etoricoxib—CYP2E1—central nervous system—epilepsy syndrome	0.000105	0.0121	CbGeAlD
Etoricoxib—CYP2E1—cerebellum—epilepsy syndrome	0.000103	0.0119	CbGeAlD
Etoricoxib—PTGS2—nervous system—epilepsy syndrome	0.000101	0.0116	CbGeAlD
Etoricoxib—PTGS2—central nervous system—epilepsy syndrome	9.69e-05	0.0112	CbGeAlD
Etoricoxib—PTGS2—cerebellum—epilepsy syndrome	9.47e-05	0.0109	CbGeAlD
Etoricoxib—CYP2D6—head—epilepsy syndrome	9.13e-05	0.0105	CbGeAlD
Etoricoxib—CYP3A4—nervous system—epilepsy syndrome	8.79e-05	0.0102	CbGeAlD
Etoricoxib—CYP2D6—nervous system—epilepsy syndrome	8.65e-05	0.00999	CbGeAlD
Etoricoxib—CYP3A4—central nervous system—epilepsy syndrome	8.47e-05	0.00977	CbGeAlD
Etoricoxib—CYP2E1—brain—epilepsy syndrome	8.35e-05	0.00964	CbGeAlD
Etoricoxib—CYP2D6—central nervous system—epilepsy syndrome	8.33e-05	0.00962	CbGeAlD
Etoricoxib—CYP2D6—cerebellum—epilepsy syndrome	8.14e-05	0.0094	CbGeAlD
Etoricoxib—PTGS2—brain—epilepsy syndrome	7.69e-05	0.00888	CbGeAlD
Etoricoxib—CYP2D6—brain—epilepsy syndrome	6.61e-05	0.00764	CbGeAlD
Etoricoxib—Nausea—Midazolam—epilepsy syndrome	3.82e-05	0.000231	CcSEcCtD
Etoricoxib—Hallucination—Topiramate—epilepsy syndrome	3.82e-05	0.000231	CcSEcCtD
Etoricoxib—Hypoaesthesia—Topiramate—epilepsy syndrome	3.82e-05	0.000231	CcSEcCtD
Etoricoxib—Muscle spasms—Gabapentin—epilepsy syndrome	3.82e-05	0.000231	CcSEcCtD
Etoricoxib—Diarrhoea—Zonisamide—epilepsy syndrome	3.81e-05	0.000231	CcSEcCtD
Etoricoxib—Pharyngitis—Topiramate—epilepsy syndrome	3.81e-05	0.000231	CcSEcCtD
Etoricoxib—Asthenia—Oxcarbazepine—epilepsy syndrome	3.81e-05	0.00023	CcSEcCtD
Etoricoxib—Pruritus—Clonazepam—epilepsy syndrome	3.8e-05	0.00023	CcSEcCtD
Etoricoxib—Vomiting—Vigabatrin—epilepsy syndrome	3.8e-05	0.00023	CcSEcCtD
Etoricoxib—Skin disorder—Valproic Acid—epilepsy syndrome	3.8e-05	0.00023	CcSEcCtD
Etoricoxib—Urinary tract disorder—Topiramate—epilepsy syndrome	3.79e-05	0.000229	CcSEcCtD
Etoricoxib—Oedema peripheral—Topiramate—epilepsy syndrome	3.78e-05	0.000229	CcSEcCtD
Etoricoxib—Cough—Pregabalin—epilepsy syndrome	3.78e-05	0.000229	CcSEcCtD
Etoricoxib—Pruritus—Phenytoin—epilepsy syndrome	3.77e-05	0.000228	CcSEcCtD
Etoricoxib—Connective tissue disorder—Topiramate—epilepsy syndrome	3.77e-05	0.000228	CcSEcCtD
Etoricoxib—Nausea—Levetiracetam—epilepsy syndrome	3.77e-05	0.000228	CcSEcCtD
Etoricoxib—Rash—Vigabatrin—epilepsy syndrome	3.77e-05	0.000228	CcSEcCtD
Etoricoxib—Dizziness—Felbamate—epilepsy syndrome	3.76e-05	0.000228	CcSEcCtD
Etoricoxib—Dermatitis—Vigabatrin—epilepsy syndrome	3.76e-05	0.000228	CcSEcCtD
Etoricoxib—Urethral disorder—Topiramate—epilepsy syndrome	3.76e-05	0.000228	CcSEcCtD
Etoricoxib—Pruritus—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000227	CcSEcCtD
Etoricoxib—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.75e-05	0.000227	CcSEcCtD
Etoricoxib—Vision blurred—Gabapentin—epilepsy syndrome	3.74e-05	0.000227	CcSEcCtD
Etoricoxib—Headache—Vigabatrin—epilepsy syndrome	3.74e-05	0.000227	CcSEcCtD
Etoricoxib—Hypertension—Pregabalin—epilepsy syndrome	3.74e-05	0.000226	CcSEcCtD
Etoricoxib—Vomiting—Diazepam—epilepsy syndrome	3.74e-05	0.000226	CcSEcCtD
Etoricoxib—Anorexia—Valproic Acid—epilepsy syndrome	3.73e-05	0.000226	CcSEcCtD
Etoricoxib—Tremor—Gabapentin—epilepsy syndrome	3.72e-05	0.000225	CcSEcCtD
Etoricoxib—Rash—Diazepam—epilepsy syndrome	3.71e-05	0.000224	CcSEcCtD
Etoricoxib—Dermatitis—Diazepam—epilepsy syndrome	3.7e-05	0.000224	CcSEcCtD
Etoricoxib—Visual impairment—Topiramate—epilepsy syndrome	3.7e-05	0.000224	CcSEcCtD
Etoricoxib—Chest pain—Pregabalin—epilepsy syndrome	3.69e-05	0.000223	CcSEcCtD
Etoricoxib—Arthralgia—Pregabalin—epilepsy syndrome	3.69e-05	0.000223	CcSEcCtD
Etoricoxib—Dizziness—Zonisamide—epilepsy syndrome	3.68e-05	0.000223	CcSEcCtD
Etoricoxib—Headache—Diazepam—epilepsy syndrome	3.68e-05	0.000223	CcSEcCtD
Etoricoxib—Anxiety—Pregabalin—epilepsy syndrome	3.67e-05	0.000222	CcSEcCtD
Etoricoxib—Diarrhoea—Clonazepam—epilepsy syndrome	3.67e-05	0.000222	CcSEcCtD
Etoricoxib—Anaemia—Gabapentin—epilepsy syndrome	3.67e-05	0.000222	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.66e-05	0.000222	CcSEcCtD
Etoricoxib—Asthenia—Carbamazepine—epilepsy syndrome	3.65e-05	0.000221	CcSEcCtD
Etoricoxib—Agitation—Gabapentin—epilepsy syndrome	3.65e-05	0.000221	CcSEcCtD
Etoricoxib—Diarrhoea—Phenytoin—epilepsy syndrome	3.65e-05	0.000221	CcSEcCtD
Etoricoxib—Nausea—Fosphenytoin—epilepsy syndrome	3.64e-05	0.00022	CcSEcCtD
Etoricoxib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.63e-05	0.00022	CcSEcCtD
Etoricoxib—Erythema multiforme—Topiramate—epilepsy syndrome	3.63e-05	0.00022	CcSEcCtD
Etoricoxib—Angioedema—Gabapentin—epilepsy syndrome	3.63e-05	0.00022	CcSEcCtD
Etoricoxib—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.62e-05	0.000219	CcSEcCtD
Etoricoxib—Vomiting—Felbamate—epilepsy syndrome	3.62e-05	0.000219	CcSEcCtD
Etoricoxib—Dry mouth—Pregabalin—epilepsy syndrome	3.6e-05	0.000218	CcSEcCtD
Etoricoxib—Pruritus—Carbamazepine—epilepsy syndrome	3.6e-05	0.000218	CcSEcCtD
Etoricoxib—Rash—Felbamate—epilepsy syndrome	3.59e-05	0.000217	CcSEcCtD
Etoricoxib—Eye disorder—Topiramate—epilepsy syndrome	3.59e-05	0.000217	CcSEcCtD
Etoricoxib—Dermatitis—Felbamate—epilepsy syndrome	3.58e-05	0.000217	CcSEcCtD
Etoricoxib—Tinnitus—Topiramate—epilepsy syndrome	3.58e-05	0.000217	CcSEcCtD
Etoricoxib—Headache—Felbamate—epilepsy syndrome	3.56e-05	0.000216	CcSEcCtD
Etoricoxib—Confusional state—Pregabalin—epilepsy syndrome	3.56e-05	0.000216	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.56e-05	0.000216	CcSEcCtD
Etoricoxib—Flushing—Topiramate—epilepsy syndrome	3.56e-05	0.000216	CcSEcCtD
Etoricoxib—Cardiac disorder—Topiramate—epilepsy syndrome	3.56e-05	0.000216	CcSEcCtD
Etoricoxib—Dizziness—Clonazepam—epilepsy syndrome	3.55e-05	0.000215	CcSEcCtD
Etoricoxib—Nausea—Vigabatrin—epilepsy syndrome	3.55e-05	0.000215	CcSEcCtD
Etoricoxib—Vomiting—Zonisamide—epilepsy syndrome	3.54e-05	0.000214	CcSEcCtD
Etoricoxib—Insomnia—Valproic Acid—epilepsy syndrome	3.54e-05	0.000214	CcSEcCtD
Etoricoxib—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.53e-05	0.000214	CcSEcCtD
Etoricoxib—Oedema—Pregabalin—epilepsy syndrome	3.53e-05	0.000214	CcSEcCtD
Etoricoxib—Asthenia—Lamotrigine—epilepsy syndrome	3.53e-05	0.000214	CcSEcCtD
Etoricoxib—Dizziness—Phenytoin—epilepsy syndrome	3.53e-05	0.000214	CcSEcCtD
Etoricoxib—Rash—Zonisamide—epilepsy syndrome	3.51e-05	0.000213	CcSEcCtD
Etoricoxib—Infection—Pregabalin—epilepsy syndrome	3.51e-05	0.000213	CcSEcCtD
Etoricoxib—Palpitations—Gabapentin—epilepsy syndrome	3.51e-05	0.000212	CcSEcCtD
Etoricoxib—Dermatitis—Zonisamide—epilepsy syndrome	3.51e-05	0.000212	CcSEcCtD
Etoricoxib—Dizziness—Oxcarbazepine—epilepsy syndrome	3.51e-05	0.000212	CcSEcCtD
Etoricoxib—Nausea—Diazepam—epilepsy syndrome	3.49e-05	0.000211	CcSEcCtD
Etoricoxib—Headache—Zonisamide—epilepsy syndrome	3.49e-05	0.000211	CcSEcCtD
Etoricoxib—Dyspnoea—Valproic Acid—epilepsy syndrome	3.48e-05	0.000211	CcSEcCtD
Etoricoxib—Diarrhoea—Carbamazepine—epilepsy syndrome	3.48e-05	0.000211	CcSEcCtD
Etoricoxib—Angiopathy—Topiramate—epilepsy syndrome	3.48e-05	0.000211	CcSEcCtD
Etoricoxib—Pruritus—Lamotrigine—epilepsy syndrome	3.48e-05	0.000211	CcSEcCtD
Etoricoxib—Shock—Pregabalin—epilepsy syndrome	3.48e-05	0.000211	CcSEcCtD
Etoricoxib—Somnolence—Valproic Acid—epilepsy syndrome	3.47e-05	0.00021	CcSEcCtD
Etoricoxib—Immune system disorder—Topiramate—epilepsy syndrome	3.47e-05	0.00021	CcSEcCtD
Etoricoxib—Nervous system disorder—Pregabalin—epilepsy syndrome	3.47e-05	0.00021	CcSEcCtD
Etoricoxib—Cough—Gabapentin—epilepsy syndrome	3.46e-05	0.00021	CcSEcCtD
Etoricoxib—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.46e-05	0.00021	CcSEcCtD
Etoricoxib—Mediastinal disorder—Topiramate—epilepsy syndrome	3.46e-05	0.000209	CcSEcCtD
Etoricoxib—Dyspepsia—Valproic Acid—epilepsy syndrome	3.44e-05	0.000208	CcSEcCtD
Etoricoxib—Skin disorder—Pregabalin—epilepsy syndrome	3.43e-05	0.000208	CcSEcCtD
Etoricoxib—Hypertension—Gabapentin—epilepsy syndrome	3.43e-05	0.000208	CcSEcCtD
Etoricoxib—Vomiting—Clonazepam—epilepsy syndrome	3.41e-05	0.000207	CcSEcCtD
Etoricoxib—Decreased appetite—Valproic Acid—epilepsy syndrome	3.4e-05	0.000206	CcSEcCtD
Etoricoxib—Alopecia—Topiramate—epilepsy syndrome	3.39e-05	0.000205	CcSEcCtD
Etoricoxib—Vomiting—Phenytoin—epilepsy syndrome	3.39e-05	0.000205	CcSEcCtD
Etoricoxib—Rash—Clonazepam—epilepsy syndrome	3.38e-05	0.000205	CcSEcCtD
Etoricoxib—Dermatitis—Clonazepam—epilepsy syndrome	3.38e-05	0.000205	CcSEcCtD
Etoricoxib—Arthralgia—Gabapentin—epilepsy syndrome	3.38e-05	0.000205	CcSEcCtD
Etoricoxib—Chest pain—Gabapentin—epilepsy syndrome	3.38e-05	0.000205	CcSEcCtD
Etoricoxib—Nausea—Felbamate—epilepsy syndrome	3.38e-05	0.000205	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Vomiting—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Fatigue—Valproic Acid—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Anxiety—Gabapentin—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Anorexia—Pregabalin—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Dizziness—Carbamazepine—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Diarrhoea—Lamotrigine—epilepsy syndrome	3.37e-05	0.000204	CcSEcCtD
Etoricoxib—Headache—Clonazepam—epilepsy syndrome	3.36e-05	0.000204	CcSEcCtD
Etoricoxib—Rash—Phenytoin—epilepsy syndrome	3.36e-05	0.000204	CcSEcCtD
Etoricoxib—Mental disorder—Topiramate—epilepsy syndrome	3.36e-05	0.000204	CcSEcCtD
Etoricoxib—Dermatitis—Phenytoin—epilepsy syndrome	3.36e-05	0.000203	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.36e-05	0.000203	CcSEcCtD
Etoricoxib—Rash—Oxcarbazepine—epilepsy syndrome	3.34e-05	0.000203	CcSEcCtD
Etoricoxib—Pain—Valproic Acid—epilepsy syndrome	3.34e-05	0.000202	CcSEcCtD
Etoricoxib—Constipation—Valproic Acid—epilepsy syndrome	3.34e-05	0.000202	CcSEcCtD
Etoricoxib—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.34e-05	0.000202	CcSEcCtD
Etoricoxib—Headache—Phenytoin—epilepsy syndrome	3.34e-05	0.000202	CcSEcCtD
Etoricoxib—Malnutrition—Topiramate—epilepsy syndrome	3.34e-05	0.000202	CcSEcCtD
Etoricoxib—Erythema—Topiramate—epilepsy syndrome	3.34e-05	0.000202	CcSEcCtD
Etoricoxib—Headache—Oxcarbazepine—epilepsy syndrome	3.32e-05	0.000201	CcSEcCtD
Etoricoxib—Nausea—Zonisamide—epilepsy syndrome	3.31e-05	0.0002	CcSEcCtD
Etoricoxib—Dry mouth—Gabapentin—epilepsy syndrome	3.31e-05	0.0002	CcSEcCtD
Etoricoxib—Flatulence—Topiramate—epilepsy syndrome	3.29e-05	0.000199	CcSEcCtD
Etoricoxib—Dysgeusia—Topiramate—epilepsy syndrome	3.27e-05	0.000198	CcSEcCtD
Etoricoxib—Confusional state—Gabapentin—epilepsy syndrome	3.27e-05	0.000198	CcSEcCtD
Etoricoxib—Dizziness—Lamotrigine—epilepsy syndrome	3.25e-05	0.000197	CcSEcCtD
Etoricoxib—Oedema—Gabapentin—epilepsy syndrome	3.24e-05	0.000196	CcSEcCtD
Etoricoxib—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.24e-05	0.000196	CcSEcCtD
Etoricoxib—Vomiting—Carbamazepine—epilepsy syndrome	3.24e-05	0.000196	CcSEcCtD
Etoricoxib—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.22e-05	0.000195	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.22e-05	0.000195	CcSEcCtD
Etoricoxib—Infection—Gabapentin—epilepsy syndrome	3.22e-05	0.000195	CcSEcCtD
Etoricoxib—Muscle spasms—Topiramate—epilepsy syndrome	3.21e-05	0.000194	CcSEcCtD
Etoricoxib—Rash—Carbamazepine—epilepsy syndrome	3.21e-05	0.000194	CcSEcCtD
Etoricoxib—Dermatitis—Carbamazepine—epilepsy syndrome	3.21e-05	0.000194	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.2e-05	0.000194	CcSEcCtD
Etoricoxib—Insomnia—Pregabalin—epilepsy syndrome	3.2e-05	0.000194	CcSEcCtD
Etoricoxib—Nausea—Clonazepam—epilepsy syndrome	3.19e-05	0.000193	CcSEcCtD
Etoricoxib—Headache—Carbamazepine—epilepsy syndrome	3.19e-05	0.000193	CcSEcCtD
Etoricoxib—Shock—Gabapentin—epilepsy syndrome	3.19e-05	0.000193	CcSEcCtD
Etoricoxib—Nervous system disorder—Gabapentin—epilepsy syndrome	3.18e-05	0.000192	CcSEcCtD
Etoricoxib—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.17e-05	0.000192	CcSEcCtD
Etoricoxib—Nausea—Phenytoin—epilepsy syndrome	3.17e-05	0.000192	CcSEcCtD
Etoricoxib—Dyspnoea—Pregabalin—epilepsy syndrome	3.15e-05	0.000191	CcSEcCtD
Etoricoxib—Nausea—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000191	CcSEcCtD
Etoricoxib—Vision blurred—Topiramate—epilepsy syndrome	3.15e-05	0.000191	CcSEcCtD
Etoricoxib—Skin disorder—Gabapentin—epilepsy syndrome	3.15e-05	0.000191	CcSEcCtD
Etoricoxib—Somnolence—Pregabalin—epilepsy syndrome	3.14e-05	0.00019	CcSEcCtD
Etoricoxib—Tremor—Topiramate—epilepsy syndrome	3.13e-05	0.00019	CcSEcCtD
Etoricoxib—Vomiting—Lamotrigine—epilepsy syndrome	3.13e-05	0.000189	CcSEcCtD
Etoricoxib—Urticaria—Valproic Acid—epilepsy syndrome	3.11e-05	0.000188	CcSEcCtD
Etoricoxib—Rash—Lamotrigine—epilepsy syndrome	3.1e-05	0.000188	CcSEcCtD
Etoricoxib—Dermatitis—Lamotrigine—epilepsy syndrome	3.1e-05	0.000188	CcSEcCtD
Etoricoxib—Abdominal pain—Valproic Acid—epilepsy syndrome	3.09e-05	0.000187	CcSEcCtD
Etoricoxib—Anorexia—Gabapentin—epilepsy syndrome	3.09e-05	0.000187	CcSEcCtD
Etoricoxib—Anaemia—Topiramate—epilepsy syndrome	3.09e-05	0.000187	CcSEcCtD
Etoricoxib—Headache—Lamotrigine—epilepsy syndrome	3.08e-05	0.000187	CcSEcCtD
Etoricoxib—Decreased appetite—Pregabalin—epilepsy syndrome	3.07e-05	0.000186	CcSEcCtD
Etoricoxib—Agitation—Topiramate—epilepsy syndrome	3.07e-05	0.000186	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.05e-05	0.000185	CcSEcCtD
Etoricoxib—Fatigue—Pregabalin—epilepsy syndrome	3.05e-05	0.000185	CcSEcCtD
Etoricoxib—Nausea—Carbamazepine—epilepsy syndrome	3.02e-05	0.000183	CcSEcCtD
Etoricoxib—Constipation—Pregabalin—epilepsy syndrome	3.02e-05	0.000183	CcSEcCtD
Etoricoxib—Pain—Pregabalin—epilepsy syndrome	3.02e-05	0.000183	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.95e-05	0.000179	CcSEcCtD
Etoricoxib—Palpitations—Topiramate—epilepsy syndrome	2.95e-05	0.000179	CcSEcCtD
Etoricoxib—Insomnia—Gabapentin—epilepsy syndrome	2.93e-05	0.000177	CcSEcCtD
Etoricoxib—Nausea—Lamotrigine—epilepsy syndrome	2.92e-05	0.000177	CcSEcCtD
Etoricoxib—Cough—Topiramate—epilepsy syndrome	2.91e-05	0.000177	CcSEcCtD
Etoricoxib—Feeling abnormal—Pregabalin—epilepsy syndrome	2.91e-05	0.000176	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.89e-05	0.000175	CcSEcCtD
Etoricoxib—Dyspnoea—Gabapentin—epilepsy syndrome	2.89e-05	0.000175	CcSEcCtD
Etoricoxib—Hypertension—Topiramate—epilepsy syndrome	2.88e-05	0.000175	CcSEcCtD
Etoricoxib—Somnolence—Gabapentin—epilepsy syndrome	2.88e-05	0.000174	CcSEcCtD
Etoricoxib—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.88e-05	0.000174	CcSEcCtD
Etoricoxib—Dyspepsia—Gabapentin—epilepsy syndrome	2.85e-05	0.000173	CcSEcCtD
Etoricoxib—Arthralgia—Topiramate—epilepsy syndrome	2.84e-05	0.000172	CcSEcCtD
Etoricoxib—Chest pain—Topiramate—epilepsy syndrome	2.84e-05	0.000172	CcSEcCtD
Etoricoxib—Anxiety—Topiramate—epilepsy syndrome	2.83e-05	0.000172	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.82e-05	0.000171	CcSEcCtD
Etoricoxib—Decreased appetite—Gabapentin—epilepsy syndrome	2.82e-05	0.000171	CcSEcCtD
Etoricoxib—Urticaria—Pregabalin—epilepsy syndrome	2.81e-05	0.00017	CcSEcCtD
Etoricoxib—Asthenia—Valproic Acid—epilepsy syndrome	2.8e-05	0.00017	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.8e-05	0.000169	CcSEcCtD
Etoricoxib—Fatigue—Gabapentin—epilepsy syndrome	2.79e-05	0.000169	CcSEcCtD
Etoricoxib—Abdominal pain—Pregabalin—epilepsy syndrome	2.79e-05	0.000169	CcSEcCtD
Etoricoxib—Dry mouth—Topiramate—epilepsy syndrome	2.78e-05	0.000168	CcSEcCtD
Etoricoxib—Pain—Gabapentin—epilepsy syndrome	2.77e-05	0.000168	CcSEcCtD
Etoricoxib—Constipation—Gabapentin—epilepsy syndrome	2.77e-05	0.000168	CcSEcCtD
Etoricoxib—Pruritus—Valproic Acid—epilepsy syndrome	2.77e-05	0.000167	CcSEcCtD
Etoricoxib—Confusional state—Topiramate—epilepsy syndrome	2.75e-05	0.000166	CcSEcCtD
Etoricoxib—Oedema—Topiramate—epilepsy syndrome	2.73e-05	0.000165	CcSEcCtD
Etoricoxib—Infection—Topiramate—epilepsy syndrome	2.71e-05	0.000164	CcSEcCtD
Etoricoxib—Shock—Topiramate—epilepsy syndrome	2.68e-05	0.000162	CcSEcCtD
Etoricoxib—Diarrhoea—Valproic Acid—epilepsy syndrome	2.67e-05	0.000162	CcSEcCtD
Etoricoxib—Nervous system disorder—Topiramate—epilepsy syndrome	2.67e-05	0.000162	CcSEcCtD
Etoricoxib—Feeling abnormal—Gabapentin—epilepsy syndrome	2.67e-05	0.000162	CcSEcCtD
Etoricoxib—Thrombocytopenia—Topiramate—epilepsy syndrome	2.67e-05	0.000162	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.65e-05	0.00016	CcSEcCtD
Etoricoxib—Skin disorder—Topiramate—epilepsy syndrome	2.65e-05	0.00016	CcSEcCtD
Etoricoxib—Hypersensitivity—Pregabalin—epilepsy syndrome	2.6e-05	0.000158	CcSEcCtD
Etoricoxib—Anorexia—Topiramate—epilepsy syndrome	2.6e-05	0.000157	CcSEcCtD
Etoricoxib—Dizziness—Valproic Acid—epilepsy syndrome	2.58e-05	0.000157	CcSEcCtD
Etoricoxib—Urticaria—Gabapentin—epilepsy syndrome	2.57e-05	0.000156	CcSEcCtD
Etoricoxib—Abdominal pain—Gabapentin—epilepsy syndrome	2.56e-05	0.000155	CcSEcCtD
Etoricoxib—Asthenia—Pregabalin—epilepsy syndrome	2.54e-05	0.000154	CcSEcCtD
Etoricoxib—Pruritus—Pregabalin—epilepsy syndrome	2.5e-05	0.000151	CcSEcCtD
Etoricoxib—Vomiting—Valproic Acid—epilepsy syndrome	2.49e-05	0.000151	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.48e-05	0.00015	CcSEcCtD
Etoricoxib—Insomnia—Topiramate—epilepsy syndrome	2.47e-05	0.000149	CcSEcCtD
Etoricoxib—Rash—Valproic Acid—epilepsy syndrome	2.46e-05	0.000149	CcSEcCtD
Etoricoxib—Dermatitis—Valproic Acid—epilepsy syndrome	2.46e-05	0.000149	CcSEcCtD
Etoricoxib—Headache—Valproic Acid—epilepsy syndrome	2.45e-05	0.000148	CcSEcCtD
Etoricoxib—Dyspnoea—Topiramate—epilepsy syndrome	2.43e-05	0.000147	CcSEcCtD
Etoricoxib—Somnolence—Topiramate—epilepsy syndrome	2.42e-05	0.000147	CcSEcCtD
Etoricoxib—Diarrhoea—Pregabalin—epilepsy syndrome	2.42e-05	0.000146	CcSEcCtD
Etoricoxib—Dyspepsia—Topiramate—epilepsy syndrome	2.4e-05	0.000145	CcSEcCtD
Etoricoxib—Hypersensitivity—Gabapentin—epilepsy syndrome	2.39e-05	0.000145	CcSEcCtD
Etoricoxib—Decreased appetite—Topiramate—epilepsy syndrome	2.37e-05	0.000144	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.35e-05	0.000143	CcSEcCtD
Etoricoxib—Fatigue—Topiramate—epilepsy syndrome	2.35e-05	0.000142	CcSEcCtD
Etoricoxib—Dizziness—Pregabalin—epilepsy syndrome	2.34e-05	0.000142	CcSEcCtD
Etoricoxib—Constipation—Topiramate—epilepsy syndrome	2.33e-05	0.000141	CcSEcCtD
Etoricoxib—Pain—Topiramate—epilepsy syndrome	2.33e-05	0.000141	CcSEcCtD
Etoricoxib—Asthenia—Gabapentin—epilepsy syndrome	2.32e-05	0.000141	CcSEcCtD
Etoricoxib—Nausea—Valproic Acid—epilepsy syndrome	2.32e-05	0.000141	CcSEcCtD
Etoricoxib—Pruritus—Gabapentin—epilepsy syndrome	2.29e-05	0.000139	CcSEcCtD
Etoricoxib—Vomiting—Pregabalin—epilepsy syndrome	2.25e-05	0.000136	CcSEcCtD
Etoricoxib—Feeling abnormal—Topiramate—epilepsy syndrome	2.25e-05	0.000136	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.23e-05	0.000135	CcSEcCtD
Etoricoxib—Rash—Pregabalin—epilepsy syndrome	2.23e-05	0.000135	CcSEcCtD
Etoricoxib—Dermatitis—Pregabalin—epilepsy syndrome	2.23e-05	0.000135	CcSEcCtD
Etoricoxib—Diarrhoea—Gabapentin—epilepsy syndrome	2.22e-05	0.000134	CcSEcCtD
Etoricoxib—Headache—Pregabalin—epilepsy syndrome	2.21e-05	0.000134	CcSEcCtD
Etoricoxib—Urticaria—Topiramate—epilepsy syndrome	2.17e-05	0.000131	CcSEcCtD
Etoricoxib—Abdominal pain—Topiramate—epilepsy syndrome	2.15e-05	0.000131	CcSEcCtD
Etoricoxib—Dizziness—Gabapentin—epilepsy syndrome	2.14e-05	0.00013	CcSEcCtD
Etoricoxib—Nausea—Pregabalin—epilepsy syndrome	2.1e-05	0.000127	CcSEcCtD
Etoricoxib—Vomiting—Gabapentin—epilepsy syndrome	2.06e-05	0.000125	CcSEcCtD
Etoricoxib—Rash—Gabapentin—epilepsy syndrome	2.04e-05	0.000124	CcSEcCtD
Etoricoxib—Dermatitis—Gabapentin—epilepsy syndrome	2.04e-05	0.000124	CcSEcCtD
Etoricoxib—Headache—Gabapentin—epilepsy syndrome	2.03e-05	0.000123	CcSEcCtD
Etoricoxib—Hypersensitivity—Topiramate—epilepsy syndrome	2.01e-05	0.000122	CcSEcCtD
Etoricoxib—Asthenia—Topiramate—epilepsy syndrome	1.96e-05	0.000118	CcSEcCtD
Etoricoxib—Pruritus—Topiramate—epilepsy syndrome	1.93e-05	0.000117	CcSEcCtD
Etoricoxib—Nausea—Gabapentin—epilepsy syndrome	1.92e-05	0.000117	CcSEcCtD
Etoricoxib—Diarrhoea—Topiramate—epilepsy syndrome	1.87e-05	0.000113	CcSEcCtD
Etoricoxib—Dizziness—Topiramate—epilepsy syndrome	1.8e-05	0.000109	CcSEcCtD
Etoricoxib—Vomiting—Topiramate—epilepsy syndrome	1.73e-05	0.000105	CcSEcCtD
Etoricoxib—Rash—Topiramate—epilepsy syndrome	1.72e-05	0.000104	CcSEcCtD
Etoricoxib—Dermatitis—Topiramate—epilepsy syndrome	1.72e-05	0.000104	CcSEcCtD
Etoricoxib—Headache—Topiramate—epilepsy syndrome	1.71e-05	0.000103	CcSEcCtD
Etoricoxib—Nausea—Topiramate—epilepsy syndrome	1.62e-05	9.81e-05	CcSEcCtD
Etoricoxib—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.29e-06	6.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JUNB—epilepsy syndrome	5.27e-06	6.44e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.25e-06	6.42e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADAM10—epilepsy syndrome	5.24e-06	6.41e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS1—epilepsy syndrome	5.23e-06	6.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.2e-06	6.36e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.19e-06	6.35e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	5.16e-06	6.31e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	5.15e-06	6.3e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	5.15e-06	6.3e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	5.12e-06	6.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—epilepsy syndrome	5.1e-06	6.24e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.09e-06	6.23e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.05e-06	6.17e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.04e-06	6.16e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.03e-06	6.15e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.03e-06	6.15e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.03e-06	6.15e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.01e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.01e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HBEGF—epilepsy syndrome	4.99e-06	6.1e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—S100B—epilepsy syndrome	4.96e-06	6.06e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.94e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.93e-06	6.03e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	4.91e-06	6.01e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SOCS3—epilepsy syndrome	4.91e-06	6e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDC42—epilepsy syndrome	4.9e-06	5.99e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT3—epilepsy syndrome	4.9e-06	5.99e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FOS—epilepsy syndrome	4.88e-06	5.97e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.85e-06	5.93e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.84e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.84e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ADAM10—epilepsy syndrome	4.78e-06	5.85e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CASP8—epilepsy syndrome	4.77e-06	5.83e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	4.75e-06	5.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AVP—epilepsy syndrome	4.74e-06	5.8e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	4.68e-06	5.72e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.67e-06	5.72e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.67e-06	5.72e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.66e-06	5.7e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BCHE—epilepsy syndrome	4.66e-06	5.7e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	4.62e-06	5.66e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.61e-06	5.63e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.61e-06	5.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.57e-06	5.59e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.57e-06	5.58e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.57e-06	5.58e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HES1—epilepsy syndrome	4.48e-06	5.48e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDC42—epilepsy syndrome	4.47e-06	5.46e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	4.44e-06	5.44e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	4.44e-06	5.43e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.4e-06	5.38e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PLCB1—epilepsy syndrome	4.39e-06	5.37e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.39e-06	5.37e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.38e-06	5.36e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TH—epilepsy syndrome	4.38e-06	5.36e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FYN—epilepsy syndrome	4.36e-06	5.33e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—H2AFX—epilepsy syndrome	4.34e-06	5.31e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MEF2C—epilepsy syndrome	4.34e-06	5.3e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AQP1—epilepsy syndrome	4.31e-06	5.28e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FGF2—epilepsy syndrome	4.31e-06	5.27e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.27e-06	5.23e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.25e-06	5.2e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—YWHAZ—epilepsy syndrome	4.19e-06	5.13e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.18e-06	5.12e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.17e-06	5.1e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.16e-06	5.09e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.16e-06	5.09e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.14e-06	5.07e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NGF—epilepsy syndrome	4.14e-06	5.07e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	4.14e-06	5.06e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TH—epilepsy syndrome	4.12e-06	5.04e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BCL2—epilepsy syndrome	4.09e-06	5e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HES1—epilepsy syndrome	4.09e-06	5e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.08e-06	4.99e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—epilepsy syndrome	4.03e-06	4.93e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RELA—epilepsy syndrome	4e-06	4.89e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FYN—epilepsy syndrome	3.98e-06	4.86e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.97e-06	4.86e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.97e-06	4.86e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—H2AFX—epilepsy syndrome	3.96e-06	4.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.95e-06	4.84e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2A—epilepsy syndrome	3.94e-06	4.82e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.92e-06	4.8e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MTOR—epilepsy syndrome	3.92e-06	4.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.9e-06	4.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.9e-06	4.77e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.89e-06	4.76e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—YWHAZ—epilepsy syndrome	3.82e-06	4.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.81e-06	4.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—AKT1—epilepsy syndrome	3.8e-06	4.64e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.75e-06	4.59e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSC2—epilepsy syndrome	3.75e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AGT—epilepsy syndrome	3.74e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.74e-06	4.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—AKT1—epilepsy syndrome	3.72e-06	4.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.72e-06	4.55e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—epilepsy syndrome	3.68e-06	4.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOE—epilepsy syndrome	3.67e-06	4.49e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.67e-06	4.48e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.66e-06	4.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HMOX1—epilepsy syndrome	3.65e-06	4.47e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.64e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.63e-06	4.44e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.63e-06	4.44e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—epilepsy syndrome	3.62e-06	4.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CAT—epilepsy syndrome	3.61e-06	4.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.6e-06	4.41e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KDR—epilepsy syndrome	3.59e-06	4.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.58e-06	4.38e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.58e-06	4.38e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.57e-06	4.36e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.56e-06	4.35e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCB1—epilepsy syndrome	3.51e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JUN—epilepsy syndrome	3.5e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKCB—epilepsy syndrome	3.46e-06	4.23e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6ST—epilepsy syndrome	3.44e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.44e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.43e-06	4.19e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TSC2—epilepsy syndrome	3.42e-06	4.18e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.4e-06	4.15e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.39e-06	4.15e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—AKT1—epilepsy syndrome	3.35e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOE—epilepsy syndrome	3.35e-06	4.09e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.33e-06	4.07e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.3e-06	4.04e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.26e-06	3.99e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GPX1—epilepsy syndrome	3.26e-06	3.99e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.25e-06	3.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.23e-06	3.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.19e-06	3.9e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.18e-06	3.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TH—epilepsy syndrome	3.18e-06	3.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—epilepsy syndrome	3.15e-06	3.85e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—SRC—epilepsy syndrome	3.14e-06	3.84e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6ST—epilepsy syndrome	3.14e-06	3.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.13e-06	3.83e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—epilepsy syndrome	3.12e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.11e-06	3.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.1e-06	3.79e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.1e-06	3.79e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.08e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—epilepsy syndrome	3.08e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.08e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.07e-06	3.75e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.06e-06	3.74e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.01e-06	3.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.01e-06	3.68e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.97e-06	3.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.94e-06	3.6e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.94e-06	3.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TH—epilepsy syndrome	2.92e-06	3.58e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.91e-06	3.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TH—epilepsy syndrome	2.9e-06	3.55e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AGT—epilepsy syndrome	2.86e-06	3.5e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.85e-06	3.49e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOE—epilepsy syndrome	2.8e-06	3.43e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.79e-06	3.41e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGF2—epilepsy syndrome	2.79e-06	3.41e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.78e-06	3.4e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AGT—epilepsy syndrome	2.69e-06	3.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.65e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.65e-06	3.24e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.64e-06	3.23e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.64e-06	3.22e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.62e-06	3.2e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—epilepsy syndrome	2.59e-06	3.16e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGF2—epilepsy syndrome	2.54e-06	3.11e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MTOR—epilepsy syndrome	2.54e-06	3.1e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.51e-06	3.08e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.49e-06	3.04e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TH—epilepsy syndrome	2.48e-06	3.03e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.45e-06	3e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.44e-06	2.99e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.44e-06	2.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.42e-06	2.96e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.41e-06	2.95e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—epilepsy syndrome	2.41e-06	2.94e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.39e-06	2.93e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.39e-06	2.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.38e-06	2.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.37e-06	2.9e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.34e-06	2.87e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—epilepsy syndrome	2.33e-06	2.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.32e-06	2.84e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTOR—epilepsy syndrome	2.31e-06	2.83e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.27e-06	2.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUN—epilepsy syndrome	2.27e-06	2.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—epilepsy syndrome	2.2e-06	2.7e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—epilepsy syndrome	2.19e-06	2.68e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.18e-06	2.66e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.16e-06	2.64e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.15e-06	2.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.08e-06	2.54e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.07e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.07e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.04e-06	2.5e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.04e-06	2.5e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.03e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.03e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SRC—epilepsy syndrome	2.03e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.98e-06	2.43e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—epilepsy syndrome	1.98e-06	2.42e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—epilepsy syndrome	1.95e-06	2.39e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—epilepsy syndrome	1.94e-06	2.38e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.94e-06	2.37e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.92e-06	2.35e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TH—epilepsy syndrome	1.91e-06	2.34e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.91e-06	2.34e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.89e-06	2.32e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.87e-06	2.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.86e-06	2.27e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SRC—epilepsy syndrome	1.85e-06	2.27e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.85e-06	2.26e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.81e-06	2.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.75e-06	2.14e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.62e-06	1.98e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.61e-06	1.97e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.6e-06	1.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.59e-06	1.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.59e-06	1.95e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.59e-06	1.94e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.57e-06	1.93e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.53e-06	1.87e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.47e-06	1.79e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.45e-06	1.78e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.42e-06	1.74e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.39e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.36e-06	1.67e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.28e-06	1.57e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.27e-06	1.55e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—epilepsy syndrome	1.26e-06	1.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.25e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.24e-06	1.52e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.5e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—epilepsy syndrome	1.15e-06	1.41e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	1.33e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.29e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—epilepsy syndrome	9.65e-07	1.18e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.58e-07	1.17e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—epilepsy syndrome	9.08e-07	1.11e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.38e-07	1.03e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.01e-07	8.57e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.44e-07	7.88e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.39e-07	7.81e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—epilepsy syndrome	5.46e-07	6.68e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.21e-07	5.15e-06	CbGpPWpGaD
